Albemarle Corporatio

ALB
Real-time BATS EXCHANGE - 10/15 04:00:08 pm
68.355USD
+0.44%
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Sales 3 375 3 645
EBITDA 1 007 1 082
Operating profit (EBIT) 806 850
Pre-Tax Profit (EBT) 795 800
Net income 694 690
P/E ratio 12,2x 10,6x
EPS ( $ ) 6,34 6,41
Dividend per Share ( $ ) 1,34 1,42
Yield 1,74% 2,09%
Reference price ( $ ) 77,070 67,870
Announcement Date 02/20/2019
09:15pm
-
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2018 2019 (e)
Debt 1 150 1 878
Finance - -
Operating income (EBITDA) 1 007 1 082
Leverage
(Debt/EBITDA)
1,14x 1,74x
Capital Expenditure 700 963
Free Cash Flow (FCF) -154 -277
Book Value Per Share (BVPS) ( $ ) 32,8 38,1
Cash Flow per Share ( $ ) 4,99 7,38
Announcement Date 02/20/2019
09:15pm
-
Balance Sheet Analysis
Financial Ratios
Size 2019e 2020e
Capitalization 7 193 M $ -
Entreprise Value (EV) 9 072 M $ 9 269 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 10,6x 10,3x
Capitalization / Revenue 1,97x 1,85x
EV / Revenue 2,49x 2,33x
EV / EBITDA 8,38x 7,80x
Yield (DPS / Price) 2,09% 2,15%
Price to book (Price / BVPS) 1,78x 1,55x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 23,3% 23,4%
Operating Leverage (Delta EBIT / Delta Sales) 0,68x 1,03x
Net Margin (Net Profit / Revenue) 18,9% 18,2%
ROA (Net Profit / Asset) 8,08% 7,30%
ROE (Net Profit / Equities) 17,5% 15,4%
Rate of Dividend 22,2% 22,1%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   26,4% 23,2%
Cash Flow / Sales 21,5% 22,0%
Capital Intensity (Assets / Sales) 2,34x 2,50x
Financial Leverage (Net Debt / EBITDA) 1,74x 1,78x
Price Earning Ratio
BNA & Dividende